S 1702 · in committee · major
Access to Prescription Digital Therapeutics Act of 2025
- healthcare
What this bill does
- The bill requires Medicare and Medicaid to cover prescription digital therapeutics, which are software apps that prevent, manage, or treat medical conditions.
- Healthcare providers, manufacturers of digital therapeutics, and Medicare/Medicaid beneficiaries are affected by this coverage expansion.
- CMS must establish a payment methodology for manufacturers, who must report data on private payor coverage or face civil penalties.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How should Medicare and Medicaid determine fair payment rates for digital therapeutics compared to traditional medications or treatments?
- 02
What data should manufacturers be required to report about their digital therapeutics' effectiveness, and who should validate that information?
- 03
What are the potential cost implications for Medicare and Medicaid if they must cover digital therapeutics alongside existing treatment options?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-WV
Shelley Moore Capito
Citizen cosponsors
0
In Congress
3/ 100
Senators cosponsoring
Introduced 2025-05-08
Joining the bill
Legislative timeline
2025-05-08 · senate · IntroReferral
Read twice and referred to the Committee on Finance.
2025-05-08 · IntroReferral
Introduced in Senate
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.